Multiple executives are putting personal capital into their own
stocks. Here are the names. ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏



 

[Morning Watchlist]

_You are receiving this email because you are subscribed to BEHIND THE
MARKETS. If you no longer wish to receive these emails,
please unsubscribe
[[link removed]] here._

_Prefer to view this content on our website? Click here.
[[link removed]]
_

-------------------------

Dear Fellow Investor,

3 STOCKS INSIDERS ARE BUYING... AND WHY INVESTORS SHOULD CARE

When corporate insiders buy shares of their own company, especially in
open-market transactions, it’s worth paying attention. These are the
people with the closest view of sales pipelines, customer churn,
pricing power, cost pressures, and what’s really happening inside
the business. While insider buying is not a guarantee of future
returns, it can be a high-signal data point when it shows up as a
_cluster_ (multiple insiders buying around the same time) and when
purchases are made with _personal capital_ rather than through routine
equity compensation.

Below are three stocks that have recently seen notable insider buying
activity. For each, I’ll summarize what the company does, what
insiders bought, and how to think about the opportunity and risks.

-------------------------

1) RAPID7, INC. (SYM: RPD)

RECENT PRICE: about $15.89
INSIDER ACTIVITY (CLUSTER BUYING): In late November 2025, Rapid7 saw a
wave of open-market purchases from multiple insiders and a large
shareholder.

WHAT INSIDERS DID (HIGH LEVEL):

*
JANA PARTNERS MANAGEMENT (a >10% owner) reported open-market purchases
including 150,000 SHARES AT ~$14.13 and 50,000 SHARES AT ~$15.01.

*
JANA also disclosed another purchase of 41,545 SHARES AT ~$15.71
(about $652,672).

*
CEO COREY THOMAS purchased 14,500 SHARES AT A WEIGHTED AVERAGE ~$13.82
(about $200,390). 

*
Directors THOMAS SCHODORF (6,300 SHARES) and MARC EVAN BROWN (3,000
SHARES), plus director MIKE BURNS (2,000 SHARES), also bought in the
open market.
[[link removed]]

Put together, these filings imply roughly $3.9 MILLION in open-market
buying across FIVE INSIDERS/INSIDER ENTITIES over a short window
(based on the reported transaction values above). 

WHAT THE COMPANY DOES: Rapid7 is a cybersecurity company focused on
vulnerability management, detection/response, and security
analytics—tools enterprises use to identify exposures and respond to
threats.

WHY THE INSIDER BUYS MAY MATTER:

*
ACTIVIST INVOLVEMENT CAN BE CATALYTIC. Rapid7 previously reached a
settlement with activist investor JANA Partners to add directors to
the board, reflecting active pressure to improve execution and
shareholder value. 

*
“MANY BUYERS, SAME TIME” IS THE POINT. A single insider buy can be
noise; clustered buying suggests a broader internal view that the
risk/reward is improving at current prices.

WHAT TO WATCH (PRACTICAL CHECKLIST):

*
Evidence of STABILIZING GROWTH (billings/revenue) and IMPROVING
MARGINS.

*
Any updates around STRATEGIC ALTERNATIVES and capital allocation. 

*
Continued insider behavior: do buys persist if the stock rises?

KEY RISKS: Cybersecurity spending can be cyclical for mid-market
customers; competitive intensity is high; activist situations can take
longer than expected to translate into fundamentals.

-------------------------

_Banyan Hill_

THE ELON MUSK “MYSTERY METAL” THAT COULD BREAK CHINA’S GRIP
[[link removed]]

[MYSTERY METAL]
[[link removed]]

Trump called America's rare-earth dependence a "national emergency."
But one potential breakthrough… quietly engineered by Elon Musk…
could end that crisis forever.

And one tiny company is sitting at the center of it all. Musk is
expected to make an announcement any day now. SEE MORE ABOUT THIS
SECRET PROJECT HERE.
[[link removed]]

-------------------------

[[link removed]]2)
Park Dental Partners, Inc. (SYM: PARK)

RECENT PRICE: about $13.80
CONTEXT: Park Dental Partners recently completed its IPO and began
trading on Nasdaq on DECEMBER 3, 2025, under ticker PARK.

INSIDER ACTIVITY (CLUSTER BUYING): A set of C-suite executives and
directors disclosed purchases around the IPO period. For example:

*
CEO/Chairman PETER G. SWENSON disclosed purchases including 3,846
SHARES AT $13 (about $49,998) and an additional buy of 3,169 SHARES AT
$13 (about $41.2K).

*
Multiple additional executives/directors also reported buying at $13
(Form 4 activity summarized as a multi-insider cluster). 

Aggregating the disclosed buys in that cluster points to roughly $351K
purchased across SIX INSIDERS, concentrated at the IPO price level.
[[link removed]]

WHAT THE COMPANY DOES: Park Dental Partners operates as a dental
resource organization, providing management and operational support
services to affiliated dental practices (Minnesota and Wisconsin),
enabling clinicians to focus on patient care.

WHY THE INSIDER BUYS MAY MATTER:

*
ALIGNMENT POST-IPO. Right after a public listing, insider purchases
can signal that leadership is comfortable owning stock at the new
public-market valuation, not just holding pre-IPO equity.

*
HEALTHCARE SERVICES STABILITY. Dental demand can be resilient over
time, and scaled support services can improve practice-level economics
if executed well.

WHAT TO WATCH:

*
Post-IPO disclosures around CLINIC PRODUCTIVITY, NEW PRACTICE
ADDITIONS, and MARGIN PROFILE.

*
Whether the company deploys IPO proceeds into ACCRETIVE EXPANSION
(organic + M&A) consistent with its stated plans. 

KEY RISKS: Newly public companies can be volatile; integration risk is
real in practice roll-ups; reimbursement and labor dynamics can
pressure margins.

-------------------------

_Trade Algo_

IS THIS YOUR NEW #1 ENEMY IN TRADING?
[[link removed]]

Imagine this scenario…You are a super-intelligent investor who can
scan through millions of data, detect patterns, and execute savvy
trades… in just minutes. 

It would be an unfair advantage, right?

Welcome to the AI Age, where AI can make trading decisions in
milliseconds.

Take Minotaur Capital as an example. 

The hedge fund replaced human analysts with AI… and… ended up
beating the benchmark index by more than two times.

Here's the good news...

You can get a taste of using A.I. technology to find the top momentum
trades. 

As a Behind the Markets reader, we’d like to offer you a SPECIAL
gift where you can sign up for our SMS “dark pool alerts” for
FREE.

CLICK HERE TO CLAIM FREE SMS DARK POOL ALERTS NOW.
[[link removed]]

-------------------------

3) QUIDELORTHO CORPORATION (SYM: QDEL)

RECENT PRICE: about $28.84
INSIDER ACTIVITY (CLUSTER BUYING): QuidelOrtho has seen multiple
open-market purchases from senior leadership and directors in late
November and December.

WHAT INSIDERS DID (EXAMPLES WITH REPORTED VALUES):

*
CEO BRIAN BLASER bought 23,500 SHARES at about $21.34 (roughly
$501,490). 

*
CFO JOSEPH BUSKY (via a trust) bought 4,770 SHARES at $26.0598 (about
$124,305). 

*
Insider MARY LAKE PHD POLAN bought 1,000 SHARES (about $22,430). 

*
Director ANN RHOADS bought 750 SHARES (about $21,202.50). 

*
Director JOSEPH JR. WILKINS bought 370 SHARES (about $10,341.50). 

These transactions total approximately $679K across FIVE INSIDERS,
consistent with a meaningful “cluster buy” pattern rather than a
one-off purchase.

WHAT THE COMPANY DOES: QuidelOrtho provides diagnostic testing
solutions across lab instruments and assays, point-of-care testing,
molecular diagnostics, and transfusion medicine.

WHY THE INSIDER BUYS MAY MATTER:

*
CEO PURCHASES TEND TO CARRY WEIGHT. A CEO materially increasing
ownership is often interpreted as a high-conviction signal,
particularly after volatility. 

*
MULTIPLE FUNCTIONS BUYING. Seeing both finance leadership (CFO) and
board members buying can indicate internal agreement that the stock
price is discounting overly negative assumptions.

WHAT TO WATCH:

*
Progress on MARGIN RECOVERY, mix, and demand normalization across
product lines.

*
Management commentary on CAPITAL ALLOCATION and operational
priorities.

KEY RISKS: Diagnostics demand can fluctuate by testing cycles and
healthcare utilization; competitive and pricing pressures may persist;
turnarounds can be uneven.

-------------------------

_Stansberry_

THE NEXT BIGGEST BULL RUN IN OVER 50 YEARS
[[link removed]]

Gold has shattered records, soaring past $4,000 an ounce...

BUT STANSBERRY SENIOR PARTNER DR. DAVID "DOC" EIFRIG SAYS HISTORY
SHOWS IT COULD BE ON THE VERGE OF ITS BIGGEST BULL RUN IN OVER HALF A
CENTURY.
[[link removed]]

His research shows it could be triggered by a major event, eerily
similar to what happened in the 1970s.

It's NOT inflation, fed rate cut expectations, escalating geopolitical
tensions, or anything you're likely expecting.

And Doc believes YOU MUST OWN SHARES OF HIS TOP GOLD STOCK.
[[link removed]]

He says you could 10x your money without touching a risky miner or a
boring exchange-traded fund.

GET ALL THE FACTS HERE.
[[link removed]]

It's the centerpiece of Doc's full gameplan for this wild market, with
extraordinary upside potential.

CLICK HERE FOR THE FULL DETAILS ON THIS DEVELOPING GOLD STORY.
[[link removed]]

-------------------------

_Are there any other stocks with recent insider buys that you've got
your eye on? What other sectors of the market are you currently
interested in? Hit "reply" to this email and let us know your
thoughts!_

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431

Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the
Markets. For more information about our privacy practices, please
review our Privacy Policy
[[link removed]]
or our Legal Notices.
[[link removed]]

Behind the Markets
[[link removed]]

Unsubscribe
[[link removed]]

invisiblelink
[[link removed]]